Antihypertensie Antidiabetic Antiobesity Subcutaneous CD68 Omental CD68 DiameterS, μm 0.655, 0.158 0.878, 0.021* 0.393, 0.441 0.657, 0.156 0.486, 0.329 RadiusS, μm 0.655, 0.158 0.488, 0.326 -0.131, 0.805 0.771, 0.072 0.600, 0.208 AreaS, μm2 0.655, 0.158 0.878, 0.021* 0.393, 0.441 0.714, 0.111 0.429, 0.397 DiameterO, μm 0.131, 0.805 0.878, 0.021* 0.393, 0.441 0.771, 0.072 0.829, 0.042* RadiusO, μm -0.310, 0.550 -0.693, 0.127 -0.310, 0.550 -0.845, 0.034* -0.778, 0.069 AreaO, μm 0.131, 0.805 0.878, 0.021* 0.393, 0.441 0.771, 0.072 0.829, 0.042* Values are expressed as Spearman’s corralation coefficient (rS) and statistical (p) significance. * p < 0.05 S: Subcutaneous fat cell. O: Omental fat cell

Table 6: The correlation between drug use and CD68 expression with adipocyte morphometric parameters.